Acquisition by Rupert Vessey of 1625 shares of Bio Techne subject to Rule 16b-3

TECH Stock  USD 64.92  0.57  0.87%   
Under 62% of Bio Techne's investor base is looking to short. The analysis of overall sentiment of trading Bio Techne Corp stock suggests that many investors are alarmed at this time. Bio Techne's investing sentiment shows overall attitude of investors towards Bio Techne Corp.
  
Filed transaction by Biotechne Corp director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Bio insider trading alert for grant of common stock by Rupert Vessey, the corporate stakeholder, on 30th of October 2023. This event was filed by Biotechne Corp with SEC on 2023-10-30. Statement of changes in beneficial ownership - SEC Form 4

Bio Techne Fundamental Analysis

We analyze Bio Techne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Techne using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

9.00100.00100.0075.00100%
Bio Techne is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Bio Techne Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bio Techne stock to make a market-neutral strategy. Peer analysis of Bio Techne could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics with similar companies.

Peers

Bio Techne Related Equities

EXELExelixis   5.02   
0%
73.0%
AKROAkero Therapeutics   2.49   
0%
36.0%
LEGNLegend Biotech   2.00   
0%
29.0%
HALOHalozyme Therapeutics   0.54   
0%
7.0%
ALNYAlnylam Pharmaceuticals   0.16   
2.0%
0%
BMRNBiomarin Pharmaceutical   0.70   
10.0%
0%
ASNDAscendis Pharma   1.39   
20.0%
0%
UTHRUnited Therapeutics   1.70   
25.0%
0%
BPMCBlueprint Medicines   2.23   
32.0%
0%
REPLReplimune   2.31   
34.0%
0%
LQDALiquidia Technologies   2.36   
34.0%
0%
APLSApellis Pharmaceuticals   2.93   
43.0%
0%
VTYXVentyx Biosciences   3.01   
44.0%
0%
PCVXVaxcyte   3.31   
48.0%
0%
NUVLNuvalent   3.52   
51.0%
0%
TVTXTravere Therapeutics   6.79   
100.0%
0%

Complementary Tools for Bio Stock analysis

When running Bio Techne's price analysis, check to measure Bio Techne's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Techne is operating at the current time. Most of Bio Techne's value examination focuses on studying past and present price action to predict the probability of Bio Techne's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Techne's price. Additionally, you may evaluate how the addition of Bio Techne to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements
News Freq…Investor S…